National Institute of Diabetes and Digestive and Kidney Diseases; Notice of Closed Meetings, 23571-23572 [2013-09172]
Download as PDF
<![CDATA[
Federal Register / Vol. 78, No. 76 / Friday, April 19, 2013 / Notices
Submit your comments to
paperwork@hrsa.gov or mail the HRSA
Reports Clearance Officer, Room 10–29,
Parklawn Building, 5600 Fishers Lane,
Rockville, MD 20857.
Deadline: Comments on this
Information Collection Request must be
received within 60 days of this notice.
ADDRESSES:
Dated: April 12, 2013.
Bahar Niakan,
Director, Division of Policy and Information
Coordination.
[FR Doc. 2013–09221 Filed 4–18–13; 8:45 am]
BILLING CODE 4165–15–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Health Resources and Services
Administration
mstockstill on DSK4VPTVN1PROD with NOTICES
Advisory Council on Blood Stem Cell
Transplantation; Notice of Meeting
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), notice is hereby given
of the following meeting:
Name: Advisory Council on Blood
Stem Cell Transplantation.
Date and Time: May 16, 2013, 10:00
a.m. to 4:00 p.m. EST.
Place: The meeting will be via audio
conference call and Adobe Connect Pro.
Status: The meeting will be open to
the public.
Purpose: Pursuant to Public Law 109–
129, 42 U.S.C. 274k (section 379 of the
Public Health Service Act, as amended),
the Advisory Council on Blood Stem
Cell Transplantation (ACBSCT) advises
the Secretary of the Department of
Health and Human Services and the
Administrator, Health Resources and
Services Administration (HRSA), on
matters related to the activities of the
C.W. Bill Young Cell Transplantation
Program (Program) and the National
Cord Blood Inventory Program.
Agenda: The Council will hear reports
from ACBSCT Work Groups including:
Cord Blood Thawing and Washing;
Access to Transplantation; and
Advancing Hematopoietic Stem Cell
Transplantation for
Hemoglobinopathies. The Council will
also hear presentations and discussions
on topics including: Accreditation,
Adverse Event Reporting, and Unmet
Need. Agenda items are subject to
change as priorities indicate.
After Council discussions, members
of the public will have an opportunity
to provide comments. Because of the
Council’s full agenda and the timeframe
in which to cover the agenda topics,
public comment may be limited. All
public comments will be included in
VerDate Mar<15>2010
17:11 Apr 18, 2013
Jkt 229001
the record of the ACBSCT meeting.
Meeting summary notes will be posted
on HRSA’s Program Web site at https://
bloodcell.transplant.hrsa.gov/ABOUT/
Advisory_Council/.
The draft meeting agenda will be
posted on https://acbsctmeeting.com/
public/sitePage.aspx?key=Home. Those
participating in this meeting should
register by visiting https://
acbsctmeeting.com/public/
sitePage.aspx?key=Home. The deadline
to register for this meeting is Tuesday,
May 14, 2013. For all logistical
questions and concerns, please contact
Deborah Jones, Meeting Planner, by
calling (301) 585–1261 or by sending an
email to registration@acbsctmeeting.
com.
The public can join the meeting by:
1. (Audio Portion) Calling the
conference Phone Number 800–857–
9638 and providing the Participant Code
75841; AND
2. (Visual Portion) Connecting to the
ACBSCT Adobe Connect Pro Meeting
using the following URL: https://
hrsa.connectsolutions.com/acbsctm/
(copy and paste the link into your
browser if it does not work directly, and
enter as a guest). Participants should
call and connect 15 minutes prior to the
meeting in order for logistics to be set
up. If you have never attended an Adobe
Connect meeting, please test your
connection using the following URL:
https://hrsa.connectsolutions.com/
common/help/en/support/
meeting_test.htm and get a quick
overview by following URL: https://
www.adobe.com/go/
connectpro_overview. Call (301) 443–
0437 or send an email to
ptongele@hrsa.gov if you are having
trouble connecting to the meeting site.
Public Comment: It is preferred that
persons interested in providing an oral
presentation submit a written request,
along with a copy of their presentation
to: Passy Tongele, MBA, Division of
Transplantation, Healthcare Systems
Bureau, HRSA, 5600 Fishers Lane,
Room 12C–06, Rockville, Maryland
20857; or email at ptongele@hrsa.gov.
Requests should contain the name,
address, telephone number, email
address, and any business or
professional affiliation of the person
desiring to make an oral presentation.
Groups having similar interests are
requested to combine their comments
and present them through a single
representative.
The allocation of time may be
adjusted to accommodate the level of
expressed interest. Persons who do not
file an advance request for a
presentation, but desire to make an oral
statement, may request it at the time of
PO 00000
Frm 00035
Fmt 4703
Sfmt 4703
23571
the public comment period. Public
participation and ability to comment
will be limited to space and time as it
permits.
For Further Information Contact:
Patricia Stroup, MBA, MPA, Executive
Secretary, HSB, Healthcare Systems
Bureau, 5600 Fishers Lane, Room 12C–
06, Rockville, Maryland 20857;
telephone (301) 443–1127.
Dated: April 15, 2013.
Bahar Niakan,
Director, Division of Policy and Information
Coordination.
[FR Doc. 2013–09222 Filed 4–18–13; 8:45 am]
BILLING CODE 4165–15–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Diabetes and
Digestive and Kidney Diseases; Notice
of Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Special Emphasis Panel; NIDDK Central
Repositories Non-renewable Sample Access
(X01): Hepatitis C and Type 1 Diabetes
Biomarkers.
Date: May 9, 2013.
Time: 2:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, Two
Democracy Plaza, 6707 Democracy
Boulevard, Bethesda, MD 20892 (Telephone
Conference Call).
Contact Person: Najma Begum, Ph.D.,
Scientific Review Officer, Review Branch,
DEA, NIDDK, National Institutes of Health,
Room 749, 6707 Democracy Boulevard,
Bethesda, MD 20892–5452, (301) 594–8894,
begumn@niddk.nih.gov.
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Special Emphasis Panel; NIDDK–KUH
Fellowship Review Committee.
Date: June 3, 2013.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
E:\FR\FM\19APN1.SGM
19APN1
23572
Federal Register / Vol. 78, No. 76 / Friday, April 19, 2013 / Notices
Place: Residence Inn Bethesda, 7335
Wisconsin Avenue, Bethesda, MD 20814.
Contact Person: Xiaodu Guo, MD, Ph.D.,
Scientific Review Officer, Review Branch,
DEA, NIDDK, National Institutes of Health,
Room 761, 6707 Democracy Boulevard,
Bethesda, MD 20892–5452, (301) 594–4719,
guox@extra.niddk.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.847, Diabetes,
Endocrinology and Metabolic Research;
93.848, Digestive Diseases and Nutrition
Research; 93.849, Kidney Diseases, Urology
and Hematology Research, National Institutes
of Health, HHS)
Activities, National Institutes of Health/
NIAID, 6700B Rockledge Drive, MSC 7616,
Bethesda, MD 20892–7616, 301–435–9369,
pmehrotra@niaid.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
Dated: April 15, 2013.
David Clary,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2013–09173 Filed 4–18–13; 8:45 am]
[FR Doc. 2013–09172 Filed 4–18–13; 8:45 am]
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
BILLING CODE 4140–01–P
Dated: April 15, 2013.
David Clary,
Program Analyst, Office of Federal Advisory
Committee Policy.
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meeting
National Institutes of Health
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meeting
mstockstill on DSK4VPTVN1PROD with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel; Institutional Clinical and
Translational Science Award (U54).
Date: May 28–30, 2013.
Time: May 28, 2013, 6:00 p.m. to 9:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hilton Washington/Rockville, 1750
Rockville Pike, Rockville, MD 20852.
Time: May 29, 2013, 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hilton Washington/Rockville, 1750
Rockville Pike, Rockville, MD 20852.
Time: May 30, 2013, 8:00 a.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hilton Washington/Rockville, 1750
Rockville Pike, Rockville, MD 20852.
Contact Person: Priti Mehrotra, Ph.D.,
Chief, Immunology Review Branch, Scientific
Review Program, Division of Extramural
VerDate Mar<15>2010
17:11 Apr 18, 2013
Jkt 229001
[FR Doc. 2013–09171 Filed 4–18–13; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meeting
BILLING CODE 4140–01–P
National Institutes of Health
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Dated: April 15, 2013.
David Clary,
Program Analyst, Office of Federal Advisory
Committee Policy.
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel; Leadership Group for a
Clinical Research Network on HIV/AIDS &
HIV-associated Infections in Pediatric &
Maternal Populations.
Date: May 14–15, 2013.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Residence Inn Bethesda, 7335
Wisconsin Avenue, Bethesda, MD 20814.
Contact Person: Betty Poon, Ph.D.,
Scientific Review Officer, Scientific Review
Program, Division of Extramural Activities,
NIAID/NIH/DHHS, 6700B Rockledge Drive,
MSC 7616, Bethesda, MD 20892–7616, 301–
402–6891, poonb@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
PO 00000
Frm 00036
Fmt 4703
Sfmt 9990
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel; Institutional Clinical and
Translational Science Award (U54).
Date: May 22–24, 2013.
Time: May 22, 2013, 6:00 p.m. to 9:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hilton Washington/Rockville, 1750
Rockville Pike, Rockville, MD 20852.
Time: May 23, 2013, 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hilton Washington/Rockville, 1750
Rockville Pike, Rockville, MD 20852.
Time: May 24, 2013, 8:00 a.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hilton Washington/Rockville, 1750
Rockville Pike, Rockville, MD 20852.
Contact Person: Priti Mehrotra, Ph.D.,
Chief, Immunology Review Branch, Scientific
Review Program, Division of Extramural
Activities, National Institutes of Health/
NIAID, 6700B Rockledge Drive, MSC 7616,
Bethesda, MD 20892–7616, 301–435–9369,
pmehrotra@niaid.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
Dated: April 15, 2013.
David Clary,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2013–09174 Filed 4–18–13; 8:45 am]
BILLING CODE 4140–01–P
E:\FR\FM\19APN1.SGM
19APN1
]]>Agencies
[Federal Register Volume 78, Number 76 (Friday, April 19, 2013)]
[Notices]
[Pages 23571-23572]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-09172]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Diabetes and Digestive and Kidney Diseases;
Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of the following
meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of Diabetes and Digestive
and Kidney Diseases Special Emphasis Panel; NIDDK Central
Repositories Non-renewable Sample Access (X01): Hepatitis C and Type
1 Diabetes Biomarkers.
Date: May 9, 2013.
Time: 2:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Two Democracy Plaza, 6707
Democracy Boulevard, Bethesda, MD 20892 (Telephone Conference Call).
Contact Person: Najma Begum, Ph.D., Scientific Review Officer,
Review Branch, DEA, NIDDK, National Institutes of Health, Room 749,
6707 Democracy Boulevard, Bethesda, MD 20892-5452, (301) 594-8894,
begumn@niddk.nih.gov.
Name of Committee: National Institute of Diabetes and Digestive
and Kidney Diseases Special Emphasis Panel; NIDDK-KUH Fellowship
Review Committee.
Date: June 3, 2013.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
[[Page 23572]]
Place: Residence Inn Bethesda, 7335 Wisconsin Avenue, Bethesda,
MD 20814.
Contact Person: Xiaodu Guo, MD, Ph.D., Scientific Review
Officer, Review Branch, DEA, NIDDK, National Institutes of Health,
Room 761, 6707 Democracy Boulevard, Bethesda, MD 20892-5452, (301)
594-4719, guox@extra.niddk.nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.847,
Diabetes, Endocrinology and Metabolic Research; 93.848, Digestive
Diseases and Nutrition Research; 93.849, Kidney Diseases, Urology
and Hematology Research, National Institutes of Health, HHS)
Dated: April 15, 2013.
David Clary,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2013-09172 Filed 4-18-13; 8:45 am]
BILLING CODE 4140-01-P
